Laddar...
The evolution of recombinant thrombolytics: Current status and future directions
Cardiovascular disorders are on the rise worldwide due to alcohol abuse, obesity, hypertension, raised blood lipids, diabetes and age-related risks. The use of classical antiplatelet and anticoagulant therapies combined with surgical intervention helped to clear blood clots during the inceptive year...
Sparad:
| I publikationen: | Bioengineered |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Taylor & Francis
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5553328/ https://ncbi.nlm.nih.gov/pubmed/27696935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21655979.2016.1229718 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|